Fundraising FoxHadean Ventures — Full Portfolio
23 tracked investments · listed companies and verified rows first
Contineum is a biopharmaceutical company developing small molecule drug candidates to treat inflammatory and fibrotic diseases by modulating critical disease pathways.
BiotechHealthtech
Carmine Stengone(President and Chief Executive Officer)inCarmine N. Stengone(President, Chief Executive Officer and Director)inPeter T. Slover(Chief Financial Officer)inDaniel S. Lorrain(Chief Scientific Officer)inTimothy R. Watkins(Chief Medical Officer and Head of Development)in
Co-investorsRed Tree VentureSamsara BioCapitalCasdin CapitalFranklin TempletonJJDCSectoral Asset Management+1 more
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs.
AI & Machine LearningBiotechMedical Devices
Beatriz Llamusí(Chief Scientific Officer & Co-Founder)in
Co-investorsBpifranceColumbus Venture PartnersSound BioventuresAdBio partnersInvivo Capital Partners
Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis.
BiotechDigital HealthFemTechMedical DevicesStockholm, SE
Patric Stenberg(Founder)Gunilla Ekström(Founder)in
Co-investorsAmboy Street VenturesForeground CapitalHealthCapIndustrifondenXGEN VentureCatalyze Capital
SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.
BiotechDeep TechHealthtechMartinsried, DE
Dr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)Dr. Matthias Schneider(Co-founder & Chief Scientific Officer)Dr. Jan Poth(Managing Director, Chief Executive Officer)Dr. Jürgen Reeß(Chief Medical Officer)
Co-investorsAndera PartnersKurma PartnersBayern Kapital
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsKurma PartnersBpifrancePontifax Venture CapitalSunstone CapitalV-Bio Ventures
Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Darshan Dalal(Chief Medical Officer)in
Co-investorsM VenturesSofinnova Partners4BIO CapitalBioqube Ventures
Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer.
AI & Machine LearningDigital HealthHealthtechMedical Devices
John Drakenberg(Co-founder)inOliver Fleetwood(Co-founder)in
Co-investorsInnovestor VenturesScale Capital
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients.
BiotechDigital HealthHealthtechMedical DevicesStockholm, SE
Lars E. Gustafsson(Co-founder (deceased))
BoardMagnus Persson(Chairman of the Board)
Co-investorsEIR Ventures
CardioMech develops a transcatheter mitral valve repair system (MVRS) that delivers artificial chords via a transfemoral, transseptal catheter approach to treat degenerative mitral regurgitation on a beating heart.
BiotechHealthtechMedical DevicesTrondheim, NO
Richard Nehm(Executive Officer, Director)Jan Habrekke(Director)Vic, Jr. Bertrand(Director)Jacob Bergsland(Executive Officer, Director)Nikolai Hiorth(Executive Officer)Mark Novotny(Director)
Co-investorsInvestinor
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Co-investorsBioMedPartnerscoparionInkefFund+LSP (Life Sciences Partners)Sunstone Capital
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalGimvSeroba Life SciencesBGVBioGeneration VenturesForbion+2 more
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.
BiotechMedical Devices
Jennifer Jarrett(Chief Executive Officer & Board Director)inSherwin Sattarzadeh(Chief Operating Officer)inBecker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)inJim Baker(Chief Corporate Affairs Officer)inBrian Burkavage(Senior Vice President, Finance)in
Co-investorsEIR VenturesM VenturesSEED Capital DenmarkSeventure PartnersSunstone CapitalYsios Capital+2 more
NEL develops software-driven solutions for motion analysis and diagnostics to support epilepsy patients and their physicians.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsCatalyze CapitalMaki.vc
Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties.
AI & Machine LearningHealthtechMedical DevicesTrondheim, NO
Co-investorsSarsia Management ASInvestinor
Oncoinvent is a biotechnology company focused on drug development and commercialization in the pharmaceutical sector.
BiotechHealthtechMedical DevicesOslo, NO
Oystein Soug(CEO)inAnders Månsson(Business Executive)in
Co-investorsFarvatn Venture
Ribbon Bio develops cell-free DNA synthesis and analysis products for research and diagnostics applications.
BiotechDeep Tech
Dr. Wladimir Labeikovsky(Co-Founder, Head of Data Operations)
Co-investorsxista science venturesLansdowne Partners
SAGA Diagnostics develops molecular residual disease testing for cancer detection, combining genomic expertise to identify cancer at early treatable stages.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Roopom Banerjee(Executive Chairman)in
Co-investorsFSGLU InnovationSciety
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersCurie CapitalFund+InkefRotripBioGeneration Ventures+1 more
Themis offers lending backed by non-fungible tokens, allowing holders to deposit an NFT as collateral and borrow against it.
Neepa Patel(Founder)in
Co-investorsGhaf Capital PartnersNFXAdjuvant CapitalFelicis VenturesGlobal Health Investment FundTTV Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ARTHEx BiotechEmergence TherapeuticsThemis Bioscience
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.